Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,005 DKK | 0.00% | -4.25% | -24.44% |
Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S